Efficacy and safety of adamgammadex for reversing rocuronium‐induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study
Article in Clinical and Translational Science (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block
Article in British Journal of Anaesthesia (November 2023)
Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial
Article in Journal of Clinical Medicine (November 2022)